Sandoz Settles for $400M Over Price Fixing | Detroit News

Sandoz, a major generic drug maker, faces a $400 million settlement over allegations of price-fixing and collusion to inflate drug costs — a scheme allegedly coordinated using coded language like “fair share” and “playing nice in the sandbox.” Michigan and other states joined the probe, which began around 2010. The payout, spread over seven years starting in 2027, comes with mandatory reforms and follows earlier settlements totaling nearly $97 million. While Sandoz denies wrongdoing and still faces separate claims from commercial buyers, court approval is pending — and a trial looms for 2027. This case underscores the ongoing fight to ensure affordable medicine for consumers. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b96d84d1c0e3081d